JAMES MORGAN was named scientific director and an executive vice president of St. Jude Children’s Research Hospital. Morgan held the interim scientific director post since 2015, and was formerly chair of the Department of Developmental Neurobiology. As scientific director, Morgan will oversee the institution’s basic science programs and related research efforts. The appointment comes as...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
